Literature DB >> 3326528

Susceptibility of Nocardia asteroides to new quinolones and beta-lactams.

M E Gombert1, T M Aulicino, L duBouchet, L R Berkowitz.   

Abstract

The susceptibility of 31 strains of Nocardia asteroides to various quinolones and beta-lactams, as well as coumermycin, amikacin, and minocycline, was determined by the agar dilution technique. Ciprofloxacin was the most active fluoroquinolone tested on a weight basis, as it inhibited approximately 50% of the isolates at achievable drug levels in serum. Ceftriaxone and cefpirome were the most active cephalosporins in this system with MICs of 8 micrograms/ml for 80% of strains tested. Imipenem, amikacin, and minocycline were the most effective agents tested.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3326528      PMCID: PMC175847          DOI: 10.1128/AAC.31.12.2013

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  Pulmonary nocardiosis. Therapy with minocycline and with erythromycin plus ampicillin.

Authors:  M C Bach; A P Monaco; M Finland
Journal:  JAMA       Date:  1973-06-04       Impact factor: 56.272

2.  Pharmacokinetic characteristics of intravenous ceftriaxone in normal adults.

Authors:  A A Pollock; P E Tee; I H Patel; J Spicehandler; M S Simberkoff; J J Rahal
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

3.  Therapy of experimental cerebral nocardiosis with imipenem, amikacin, trimethoprim-sulfamethoxazole, and minocycline.

Authors:  M E Gombert; T M Aulicino; L duBouchet; G E Silverman; W M Sheinbaum
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

4.  Recent experiences with nocardial infections.

Authors:  W Rosett; G R Hodges
Journal:  Am J Med Sci       Date:  1978 Nov-Dec       Impact factor: 2.378

5.  In vitro studies of the combined effect of ampicillin and sulfonamides on Nocardia asteroides and results of therapy in four patients.

Authors:  M G Orfanakis; H G Wilcox; C B Smith
Journal:  Antimicrob Agents Chemother       Date:  1972-03       Impact factor: 5.191

6.  Nocardial infections in the United States, 1972-1974.

Authors:  B L Beaman; J Burnside; B Edwards; W Causey
Journal:  J Infect Dis       Date:  1976-09       Impact factor: 5.226

7.  Synergism of imipenem and amikacin in combination with other antibiotics against Nocardia asteroides.

Authors:  M E Gombert; T M Aulicino
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

8.  Susceptibility of Nocardia asteroides to various antibiotics, including newer beta-lactams, trimethoprim-sulfamethoxazole, amikacin, and N-formimidoyl thienamycin.

Authors:  M E Gombert
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

9.  Susceptibility of Nocardia asteroides to 46 antibiotics, including 22 beta-lactams.

Authors:  L Gutmann; F W Goldstein; M D Kitzis; B Hautefort; C Darmon; J F Acar
Journal:  Antimicrob Agents Chemother       Date:  1983-02       Impact factor: 5.191

Review 10.  Nocardial infections in the immunocompromised host: A detailed study in a defined population.

Authors:  G L Simpson; E B Stinson; M J Egger; J S Remington
Journal:  Rev Infect Dis       Date:  1981 May-Jun
View more
  10 in total

1.  Treatment of multiple subcutaneous Nocardia asteroides abscesses with ciprofloxacin and doxycycline.

Authors:  P M Bath; K W Pettingale; J Wade
Journal:  Postgrad Med J       Date:  1989-03       Impact factor: 2.401

2.  Antimicrobial susceptibility patterns of Nocardia asteroides.

Authors:  R J Wallace; L C Steele; G Sumter; J M Smith
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

3.  Effect of renal impairment on distribution of ofloxacin.

Authors:  A Sanchez Navarro; J Martinez Lanao; M M Sanchez Recio; A Domínguez-Gil Hurlé; J M Tabernero Romo; J C Gomez Sanchez; M M Terreiro Delgado
Journal:  Antimicrob Agents Chemother       Date:  1990-03       Impact factor: 5.191

4.  In vitro susceptibilities of Nocardia species to newer antimicrobial agents.

Authors:  P Berkey; D Moore; K Rolston
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

5.  In vitro susceptibility of Nocardia spp. to a new fluoroquinolone, tosufloxacin (T-3262).

Authors:  K Yazawa; Y Mikami; J Uno
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

6.  Organisms designated as Nocardia asteroides drug pattern type VI are members of the species Nocardia cyriacigeorgica.

Authors:  Patricia S Conville; Frank G Witebsky
Journal:  J Clin Microbiol       Date:  2007-05-02       Impact factor: 5.948

7.  In vitro antimicrobial susceptibilities of Nocardia species.

Authors:  N Khardori; R Shawar; R Gupta; B Rosenbaum; K Rolston
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

8.  Secular trends of nocardia infection over 15 years in a tertiary care hospital.

Authors:  R Matulionyte; P Rohner; I Uçkay; D Lew; J Garbino
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

Review 9.  Review of nocardial infections in France 1987 to 1990.

Authors:  P Boiron; F Provost; G Chevrier; B Dupont
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-08       Impact factor: 3.267

Review 10.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.